Essential Thrombocythemia — Trials

Essential Thrombocythemia — Trials · CancerIndex

Clinical trials

Registered studies

93 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 24
Recruiting: 15
Ph III recruiting: 2
Growth YoY: —
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (6)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06361641	Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes(PHEMOP)	recruiting	N/A	70	University Hospital, AngersOTHER_GOV	1	Aug 10, 2026	clinicaltrials
NCT04942080	Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI)(CALRSUIVI)	recruiting	N/A	260	University Hospital, AngersOTHER_GOV	1